EPIRUBICIN HYDROCHLORIDE

EPIRUBICIN HYDROCHLORIDE was reported 6498 times

EPIRUBICIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POST EMBOLISATION SYNDROME 23 0.2000
1 HEPATIC ARTERY STENOSIS 21 0.1615
2 COLONY STIMULATING FACTOR THERAPY 29 0.1401
3 INJECTION SITE VASCULITIS 6 0.1053
4 BLOOD BETA-D-GLUCAN ABNORMAL 2 0.1000
5 HEPATIC ARTERY OCCLUSION 7 0.0824
6 LARYNGOPHARYNGITIS 9 0.0811
7 CHEMICAL CYSTITIS 3 0.0769
8 HYPOSIDERAEMIA 5 0.0676
9 IMMUNE-MEDIATED PANCYTOPENIA 3 0.0612
10 INJECTION SITE PHLEBITIS 12 0.0513
11 OVARIAN NECROSIS 3 0.0476
12 BILE ACIDS INCREASED 7 0.0395
13 GRANULOCYTE COUNT DECREASED 68 0.0366
14 PREALBUMIN DECREASED 4 0.0333
15 HORMONE RECEPTOR POSITIVE BREAST CANCER 9 0.0331
16 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 26 0.0326
17 BLADDER NECROSIS 2 0.0312
18 CYSTATIN C INCREASED 4 0.0312
19 ISCHAEMIC ENTERITIS 3 0.0309
20 IMMUNE-MEDIATED HYPERTHYROIDISM 7 0.0276
21 IMMUNE-MEDIATED HYPOPHYSITIS 11 0.0244
22 COUGH VARIANT ASTHMA 2 0.0238
23 AORTITIS 16 0.0233
24 METASTASES TO CHEST WALL 8 0.0231
25 HEMIANOPIA 22 0.0222
26 BAROTRAUMA 2 0.0217
27 BLADDER PERFORATION 8 0.0207
28 PSYCHOLOGICAL TRAUMA 174 0.0201
29 MYELOSUPPRESSION 726 0.0201
30 ACUTE MYELOMONOCYTIC LEUKAEMIA 5 0.0198
31 LEUKAEMIA CUTIS 3 0.0195
32 SYSTEMIC SCLERODERMA 14 0.0192
33 MYXOEDEMA 4 0.0179
34 DEVICE RELATED THROMBOSIS 17 0.0172
35 ARTERIAL SPASM 3 0.0152
36 T-CELL TYPE ACUTE LEUKAEMIA 3 0.0147
37 BLOOD CHOLINESTERASE DECREASED 4 0.0146
38 CLINODACTYLY 4 0.0145
39 METASTASES TO SKIN 15 0.0145
40 BILOMA 2 0.0142
41 OVARIAN FAILURE 7 0.0131
42 HAIR DISORDER 102 0.0124
43 IMMUNE-MEDIATED THYROIDITIS 6 0.0121
44 PIK3CA-ACTIVATED MUTATION 4 0.0120
45 TROPONIN I INCREASED 20 0.0120
46 XEROPHTHALMIA 7 0.0119
47 DILATED CARDIOMYOPATHY 12 0.0119
48 ARTERITIS 7 0.0111
49 MUCOSAL TOXICITY 3 0.0111
50 SMALL CELL LUNG CANCER STAGE UNSPECIFIED 4 0.0109
51 HER2 POSITIVE BREAST CANCER 4 0.0107
52 TRANSAMINASES ABNORMAL 6 0.0103
53 ACINETOBACTER TEST POSITIVE 2 0.0103
54 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 9 0.0103
55 MYOCARDIAL OEDEMA 4 0.0101
56 IMMUNE-MEDIATED HYPOTHYROIDISM 11 0.0098
57 CEREBRAL HAEMORRHAGE NEONATAL 2 0.0094
58 CARDIAC DYSFUNCTION 35 0.0094
59 CUTANEOUS SARCOIDOSIS 4 0.0093
60 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
61 HYPERCREATINAEMIA 3 0.0091
62 ACID BASE BALANCE ABNORMAL 2 0.0089
63 MADAROSIS 102 0.0088
64 GAS GANGRENE 3 0.0087
65 FEBRILE BONE MARROW APLASIA 37 0.0087
66 HAIR COLOUR CHANGES 108 0.0087
67 VENTRICULAR DYSFUNCTION 22 0.0085
68 BLOOD CORTICOTROPHIN DECREASED 4 0.0082
69 HAIR TEXTURE ABNORMAL 109 0.0081
70 OBSESSIVE-COMPULSIVE SYMPTOM 3 0.0081
71 ADMINISTRATION SITE EXTRAVASATION 8 0.0080
72 IMMUNE-MEDIATED PANCREATITIS 3 0.0079
73 IMMUNE-MEDIATED ARTHRITIS 3 0.0079
74 CREATINE KINASE INCREASED 6 0.0078
75 LEUKOPLAKIA ORAL 4 0.0078
76 CRITICAL ILLNESS 6 0.0077
77 PROCALCITONIN INCREASED 9 0.0077
78 HEART FAILURE WITH REDUCED EJECTION FRACTION 4 0.0075
79 LYMPHOCYTE PERCENTAGE INCREASED 3 0.0074
80 PARANEOPLASTIC SYNDROME 5 0.0074
81 HEPATIC FUNCTION ABNORMAL 274 0.0073
82 ANTITHROMBIN III DECREASED 2 0.0073
83 CULTURE STOOL POSITIVE 2 0.0073
84 BLOOD FIBRINOGEN DECREASED 8 0.0070
85 PERIOSTITIS 3 0.0069
86 BLOOD CORTICOTROPHIN INCREASED 2 0.0069
87 CHEMOTHERAPY 26 0.0069
88 CARDIOTOXICITY 61 0.0068
89 ABDOMINAL SEPSIS 6 0.0068
90 ACUTE LEUKAEMIA 11 0.0068
91 NEUTROPHIL COUNT DECREASED 272 0.0067
92 IMMUNE-MEDIATED HEPATIC DISORDER 13 0.0067
93 SYSTOLIC DYSFUNCTION 7 0.0066
94 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0066
95 CONGENITAL FOOT MALFORMATION 3 0.0066
96 IMMUNE-MEDIATED NEPHRITIS 3 0.0064
97 SECOND PRIMARY MALIGNANCY 53 0.0064
98 BREAST CELLULITIS 2 0.0063
99 MYOCARDIAL INJURY 7 0.0062
100 DEFECT CONDUCTION INTRAVENTRICULAR 2 0.0062
101 CARBON DIOXIDE DECREASED 7 0.0061
102 SYNDACTYLY 5 0.0060
103 MICROGNATHIA 3 0.0060
104 ACUTE STRESS DISORDER 2 0.0060
105 HYPOCHLORAEMIA 7 0.0060
106 GRANULOCYTOPENIA 34 0.0060
107 EOSINOPHIL COUNT DECREASED 14 0.0059
108 ACUTE PROMYELOCYTIC LEUKAEMIA 6 0.0058
109 SOFT TISSUE NECROSIS 4 0.0058
110 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
111 HYPERLIPASAEMIA 3 0.0057
112 BREAST CANCER RECURRENT 18 0.0057
113 ELECTROCARDIOGRAM ST-T CHANGE 4 0.0056
114 NEUTROPHIL PERCENTAGE DECREASED 3 0.0056
115 FEBRILE NEUTROPENIA 371 0.0056
116 BRONCHOPNEUMOPATHY 2 0.0054
117 INTERLEUKIN LEVEL INCREASED 3 0.0054
118 THYROIDITIS 16 0.0053
119 JOINT ANKYLOSIS 3 0.0053
120 TRACHEITIS 4 0.0052
121 ADMINISTRATION SITE REACTION 2 0.0052
122 BONE MARROW FAILURE 102 0.0050
123 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0050
124 IMMUNE-MEDIATED DERMATITIS 5 0.0050
125 NEUTROPENIC COLITIS 10 0.0048
126 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2 0.0048
127 BLOOD CREATINE INCREASED 21 0.0047
128 IMPAIRED QUALITY OF LIFE 68 0.0047
129 EXTRAVASATION 19 0.0046
130 WHITE BLOOD CELL COUNT DECREASED 493 0.0045
131 AGRANULOCYTOSIS 84 0.0045
132 HYPERPYREXIA 19 0.0045
133 HYPOPHYSITIS 9 0.0045
134 TRIPLE NEGATIVE BREAST CANCER 3 0.0045
135 CORTISOL DECREASED 5 0.0044
136 CONGESTIVE CARDIOMYOPATHY 18 0.0043
137 PULMONARY VENO-OCCLUSIVE DISEASE 3 0.0043
138 VASOGENIC CEREBRAL OEDEMA 3 0.0042
139 HYPERTRANSAMINASAEMIA 29 0.0042
140 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 7 0.0042
141 CALCULUS URETERIC 3 0.0041
142 ANTIBIOTIC THERAPY 4 0.0041
143 BREAST CANCER METASTATIC 44 0.0041
144 HYPERAMMONAEMIC ENCEPHALOPATHY 7 0.0040
145 NEOPLASM PROGRESSION 140 0.0040
146 CATHETER SITE RELATED REACTION 3 0.0040
147 SECONDARY ADRENOCORTICAL INSUFFICIENCY 6 0.0040
148 IMMUNE-MEDIATED HEPATITIS 8 0.0039
149 NAIL DISORDER 34 0.0039
150 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
151 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
152 ONYCHOLYSIS 6 0.0038
153 BREAST CALCIFICATIONS 3 0.0038
154 LIVER INJURY 90 0.0037
155 HEPATITIS B 22 0.0036
156 HYPERURICAEMIA 15 0.0036
157 ADRENAL MASS 3 0.0036
158 EJECTION FRACTION DECREASED 56 0.0036
159 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
160 GLIOBLASTOMA MULTIFORME 3 0.0036
161 METASTASES TO MENINGES 8 0.0035
162 NEUTROPENIC SEPSIS 25 0.0035
163 MASTECTOMY 6 0.0034
164 PERIPHERAL NERVE INJURY 3 0.0034
165 RED MAN SYNDROME 3 0.0034
166 HILAR LYMPHADENOPATHY 3 0.0034
167 NECROTISING FASCIITIS 12 0.0034
168 FEBRILE INFECTION 4 0.0034
169 LIVER ABSCESS 11 0.0034
170 MONOCYTE COUNT DECREASED 4 0.0033
171 VITREOUS DETACHMENT 7 0.0032
172 MATERNAL EXPOSURE TIMING UNSPECIFIED 12 0.0032
173 HYPOPROTEINAEMIA 6 0.0032
174 BLADDER IRRITATION 2 0.0031
175 VENTRICULAR HYPOKINESIA 10 0.0031
176 METASTASES TO BONE 51 0.0031
177 ARTERIAL THROMBOSIS 6 0.0031
178 FIBRIN D DIMER INCREASED 11 0.0031
179 MUCOSAL DISORDER 3 0.0030
180 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0030
181 AUTONOMIC NEUROPATHY 3 0.0030
182 DRUG-INDUCED LIVER INJURY 92 0.0029
183 CONGENITAL HAND MALFORMATION 2 0.0029
184 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
185 METASTASES TO LIVER 51 0.0029
186 SKIN SENSITISATION 3 0.0029
187 METASTASES TO PLEURA 3 0.0029
188 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 66 0.0028
189 ACUTE MYELOID LEUKAEMIA 44 0.0028
190 CARDIOMYOPATHY 41 0.0028
191 EXPOSED BONE IN JAW 6 0.0028
192 TUMOUR PSEUDOPROGRESSION 3 0.0027
193 CANCER PAIN 7 0.0027
194 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
195 GROWTH RETARDATION 8 0.0027
196 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
197 CARDIAC HYPERTROPHY 3 0.0027
198 METASTASES TO LUNG 31 0.0027
199 ADENOCARCINOMA 6 0.0027
200 MENTAL FATIGUE 4 0.0027
201 HYPERSENSITIVITY PNEUMONITIS 3 0.0026
202 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
203 RADIOTHERAPY 5 0.0026
204 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
205 IMMUNE-MEDIATED ADVERSE REACTION 4 0.0026
206 ADMINISTRATION SITE PAIN 3 0.0026
207 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
208 TROPONIN INCREASED 19 0.0025
209 CYSTITIS HAEMORRHAGIC 10 0.0025
210 IMMUNE-MEDIATED MYOCARDITIS 4 0.0025
211 HYPOGLYCAEMIA NEONATAL 4 0.0025
212 BLOOD UREA DECREASED 3 0.0024
213 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 3 0.0024
214 CYTOLYTIC HEPATITIS 8 0.0024
215 MALIGNANT PLEURAL EFFUSION 4 0.0024
216 METASTASES TO LYMPH NODES 16 0.0024
217 TROPONIN T INCREASED 3 0.0024
218 GLUCOSE URINE PRESENT 3 0.0024
219 SEROMA 3 0.0024
220 LEUKOPENIA 117 0.0023
221 ALOPECIA 459 0.0023
222 BLOOD CHLORIDE DECREASED 6 0.0023
223 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
224 HYPERPHOSPHATAEMIA 5 0.0023
225 HYPOALBUMINAEMIA 18 0.0023
226 HYPOPITUITARISM 4 0.0023
227 LYMPHOCYTE COUNT DECREASED 40 0.0023
228 TRANSAMINASES INCREASED 50 0.0022
229 INTERSTITIAL LUNG DISEASE 107 0.0022
230 RECURRENT CANCER 9 0.0022
231 TETANY 4 0.0022
232 IMMUNE-MEDIATED LUNG DISEASE 4 0.0022
233 ADENOCARCINOMA GASTRIC 2 0.0022
234 DYSENTERY 4 0.0021
235 PHLEBITIS 11 0.0021
236 CEREBRAL TOXOPLASMOSIS 2 0.0021
237 PROTEIN TOTAL DECREASED 8 0.0021
238 HUMAN HERPESVIRUS 6 INFECTION 4 0.0021
239 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
240 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
241 POLYNEUROPATHY 25 0.0021
242 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
243 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
244 NEUTROPENIA 278 0.0020
245 LEFT VENTRICULAR FAILURE 7 0.0020
246 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
247 NEONATAL RESPIRATORY DISTRESS SYNDROME 7 0.0020
248 ACUTE PULMONARY OEDEMA 11 0.0020
249 MATERNAL DRUGS AFFECTING FOETUS 15 0.0020
250 BLAST CELL COUNT INCREASED 2 0.0019
251 MEGACOLON 3 0.0019
252 DILATATION VENTRICULAR 4 0.0019
253 HYPOPHOSPHATAEMIA 14 0.0019
254 LIPODYSTROPHY ACQUIRED 4 0.0019
255 CARDIAC FAILURE CHRONIC 8 0.0019
256 RADIATION PNEUMONITIS 4 0.0019
257 METASTATIC NEOPLASM 8 0.0019
258 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
259 HEPATIC FAILURE 55 0.0018
260 FOETAL GROWTH RESTRICTION 11 0.0018
261 VENA CAVA THROMBOSIS 3 0.0018
262 SKIN TOXICITY 10 0.0018
263 CHOLECYSTITIS ACUTE 10 0.0018
264 MUCOSAL INFLAMMATION 46 0.0018
265 OESOPHAGEAL CANDIDIASIS 7 0.0018
266 TEMPERATURE INTOLERANCE 18 0.0017
267 BLOOD CHLORIDE INCREASED 3 0.0017
268 SKIN NECROSIS 9 0.0017
269 GASTROINTESTINAL NECROSIS 5 0.0017
270 ALOPECIA AREATA 3 0.0017
271 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0017
272 ODYNOPHAGIA 10 0.0017
273 BILE DUCT STENOSIS 2 0.0017
274 VISUAL FIELD DEFECT 12 0.0017
275 NEUTROPHIL COUNT INCREASED 17 0.0017
276 SOFT TISSUE INFECTION 3 0.0016
277 AMYLASE INCREASED 6 0.0016
278 FIBROSIS 5 0.0016
279 DIASTOLIC DYSFUNCTION 5 0.0016
280 INJECTION SITE CELLULITIS 3 0.0016
281 ORGANISING PNEUMONIA 8 0.0016
282 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
283 HAEMATOTOXICITY 15 0.0016
284 ADRENAL INSUFFICIENCY 19 0.0016
285 ADRENAL DISORDER 3 0.0016
286 PULMONARY TOXICITY 11 0.0016
287 SUSPECTED OFF LABEL USE 7 0.0015
288 METASTASIS 11 0.0015
289 ASPERGILLOSIS 2 0.0015
290 PLATELET COUNT DECREASED 163 0.0015
291 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
292 POLYDIPSIA 6 0.0015
293 BLOOD ALBUMIN DECREASED 12 0.0015
294 CARDIAC FAILURE ACUTE 10 0.0015
295 OLIGOHYDRAMNIOS 5 0.0015
296 CYSTITIS NONINFECTIVE 2 0.0015
297 GASTROINTESTINAL INJURY 4 0.0015
298 BLOOD SODIUM INCREASED 4 0.0015
299 TONGUE ULCERATION 5 0.0015
300 MUSCLE CONTRACTURE 3 0.0015
301 CLOSTRIDIAL INFECTION 5 0.0015
302 INJECTION SITE NECROSIS 3 0.0015
303 CYTOPENIA 18 0.0015
304 BLOOD PHOSPHORUS INCREASED 4 0.0015
305 BRONCHOPNEUMONIA 5 0.0015
306 GASTROINTESTINAL TOXICITY 7 0.0015
307 REGURGITATION 5 0.0015
308 ATRIAL THROMBOSIS 3 0.0014
309 CARDIAC FAILURE 116 0.0014
310 DEATH NEONATAL 2 0.0014
311 PANCYTOPENIA 80 0.0014
312 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
313 RENAL TUBULAR DISORDER 4 0.0014
314 HEPARIN-INDUCED THROMBOCYTOPENIA 7 0.0014
315 HEPATOCELLULAR INJURY 20 0.0014
316 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
317 CATHETER SITE ERYTHEMA 3 0.0014
318 MYOCARDITIS 16 0.0014
319 LYMPHOCYTOSIS 3 0.0014
320 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
321 HEPATIC LESION 6 0.0014
322 MONOCYTE COUNT INCREASED 5 0.0014
323 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
324 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
325 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
326 PARESIS 3 0.0013
327 PNEUMOCYSTIS JIROVECI PNEUMONIA 3 0.0013
328 MITRAL VALVE INCOMPETENCE 15 0.0013
329 KOUNIS SYNDROME 3 0.0013
330 C-REACTIVE PROTEIN INCREASED 48 0.0013
331 EMBOLISM VENOUS 4 0.0013
332 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
333 EOSINOPHILIC PNEUMONIA 4 0.0013
334 SARCOIDOSIS 6 0.0013
335 PULSE ABNORMAL 3 0.0012
336 CYSTITIS INTERSTITIAL 2 0.0012
337 HICCUPS 10 0.0012
338 HYPOPHAGIA 31 0.0012
339 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
340 APPENDICITIS PERFORATED 3 0.0012
341 PHYSICAL DECONDITIONING 3 0.0012
342 ALANINE AMINOTRANSFERASE INCREASED 71 0.0012
343 CATHETER SITE PAIN 3 0.0012
344 DEVICE USE ISSUE 20 0.0011
345 FACIAL PARESIS 4 0.0011
346 WHITE BLOOD CELL DISORDER 3 0.0011
347 HYPERLACTACIDAEMIA 3 0.0011
348 HYPOCALCAEMIA 21 0.0011
349 GASTROINTESTINAL DISORDER 99 0.0011
350 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
351 GASTRIC PERFORATION 3 0.0011
352 HEPATIC CYTOLYSIS 14 0.0011
353 FAECALOMA 6 0.0011
354 IMMUNE THROMBOCYTOPENIA 5 0.0011
355 EMBOLISM 9 0.0011
356 SEPTIC SHOCK 47 0.0011
357 CEREBRAL INFARCTION 26 0.0011
358 NEUTROPHIL COUNT ABNORMAL 3 0.0011
359 PREMATURE LABOUR 6 0.0011
360 NEUTROPHILIA 6 0.0011
361 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
362 NEUROPATHY PERIPHERAL 99 0.0010
363 FEEDING DISORDER 21 0.0010
364 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
365 NEUROTOXICITY 18 0.0010
366 BICYTOPENIA 2 0.0010
367 VENOUS THROMBOSIS 4 0.0010
368 HYPOKALAEMIA 47 0.0010
369 BREATH SOUNDS ABNORMAL 5 0.0010
370 ENCEPHALITIS 7 0.0010
371 HEPATITIS FULMINANT 3 0.0010
372 LARGE INTESTINE PERFORATION 7 0.0010
373 MALIGNANT NEOPLASM PROGRESSION 103 0.0010
374 BLOOD CULTURE POSITIVE 3 0.0010
375 CANDIDIASIS 4 0.0010
376 MIXED LIVER INJURY 3 0.0010
377 PYREXIA 339 0.0010
378 DYSAESTHESIA 3 0.0010
379 CEREBRAL ISCHAEMIA 5 0.0010
380 CAPILLARY LEAK SYNDROME 2 0.0010
381 THROMBOCYTOPENIA 108 0.0010
382 FOETAL DEATH 5 0.0010
383 PNEUMONITIS 26 0.0010
384 ELECTROLYTE IMBALANCE 11 0.0009
385 VASCULITIS 11 0.0009
386 BUNDLE BRANCH BLOCK LEFT 4 0.0009
387 SPLENOMEGALY 11 0.0009
388 LUNG NEOPLASM 4 0.0009
389 VULVOVAGINAL DRYNESS 3 0.0009
390 ANAL ABSCESS 5 0.0009
391 GINGIVITIS 5 0.0009
392 HEPATITIS ACUTE 6 0.0009
393 SKIN FISSURES 18 0.0009
394 DEAFNESS NEUROSENSORY 3 0.0009
395 PARONYCHIA 4 0.0009
396 OTITIS MEDIA 3 0.0009
397 INTESTINAL ISCHAEMIA 5 0.0009
398 PEPTIC ULCER 3 0.0009
399 APHTHOUS ULCER 7 0.0009
400 MOUTH ULCERATION 19 0.0009
401 SKIN MASS 6 0.0009
402 NEPHRITIS 3 0.0009
403 NECROSIS 5 0.0009
404 POST-TRAUMATIC STRESS DISORDER 6 0.0009
405 BREAST MASS 6 0.0009
406 GASTROINTESTINAL INFECTION 8 0.0009
407 ANGIOPATHY 5 0.0009
408 VOMITING 419 0.0009
409 COLITIS ISCHAEMIC 6 0.0009
410 NEOPLASM RECURRENCE 3 0.0009
411 TRICUSPID VALVE INCOMPETENCE 7 0.0009
412 GINGIVAL PAIN 7 0.0009
413 NEUROLOGICAL SYMPTOM 5 0.0009
414 SENSORY DISTURBANCE 14 0.0009
415 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
416 LYMPHOEDEMA 6 0.0009
417 ASTHENIA 326 0.0009
418 ANAEMIA 165 0.0009
419 EMOTIONAL DISTRESS 104 0.0009
420 HEPATIC ENCEPHALOPATHY 8 0.0009
421 THROMBOPHLEBITIS 3 0.0009
422 HYPERTRIGLYCERIDAEMIA 5 0.0009
423 COLD SWEAT 15 0.0009
424 DEPRESSIVE SYMPTOM 3 0.0009
425 HYPOTHYROIDISM 27 0.0008
426 SINUS TACHYCARDIA 12 0.0008
427 CARDIAC FAILURE CONGESTIVE 67 0.0008
428 BONE LESION 3 0.0008
429 TYPE 1 DIABETES MELLITUS 5 0.0008
430 DECREASED APPETITE 192 0.0008
431 BLOOD PHOSPHORUS DECREASED 3 0.0008
432 HYPONATRAEMIA 46 0.0008
433 LARYNGEAL OEDEMA 5 0.0008
434 OSTEONECROSIS OF JAW 20 0.0008
435 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
436 SUNBURN 6 0.0008
437 INFUSION SITE EXTRAVASATION 5 0.0008
438 DRUG EXPOSURE DURING PREGNANCY 27 0.0008
439 AUTOIMMUNE THYROIDITIS 3 0.0008
440 CATHETER SITE INFECTION 3 0.0008
441 BRAIN ABSCESS 2 0.0008
442 DRUG ERUPTION 14 0.0008
443 PATHOLOGICAL FRACTURE 4 0.0008
444 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
445 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
446 ENTERITIS 5 0.0008
447 LYMPHOPENIA 11 0.0008
448 CACHEXIA 4 0.0008
449 VENTRICULAR EXTRASYSTOLES 8 0.0008
450 RED BLOOD CELL COUNT DECREASED 22 0.0008
451 HYPERGLYCAEMIA 28 0.0008
452 COMPARTMENT SYNDROME 2 0.0008
453 PREMATURE BABY 23 0.0008
454 PARAESTHESIA ORAL 11 0.0008
455 ORAL CANDIDIASIS 10 0.0008
456 BACTERAEMIA 9 0.0008
457 HEART RATE IRREGULAR 17 0.0008
458 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
459 MENINGITIS 5 0.0007
460 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
461 HAEMOGLOBIN DECREASED 76 0.0007
462 PULMONARY MASS 11 0.0007
463 DYSPHAGIA 70 0.0007
464 PERIPHERAL ISCHAEMIA 3 0.0007
465 ECCHYMOSIS 5 0.0007
466 LEG AMPUTATION 3 0.0007
467 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
468 PLEURAL EFFUSION 44 0.0007
469 LEUKOCYTOSIS 13 0.0007
470 PAPULE 5 0.0007
471 MUSCLE FATIGUE 3 0.0007
472 HAEMATOCRIT DECREASED 14 0.0007
473 AORTIC VALVE INCOMPETENCE 3 0.0007
474 NAUSEA 553 0.0007
475 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
476 INJECTION SITE INDURATION 9 0.0007
477 ENTEROCOLITIS 4 0.0007
478 STOMATITIS 42 0.0007
479 MYELODYSPLASTIC SYNDROME 10 0.0007
480 HYPERTHYROIDISM 10 0.0007
481 DISCOMFORT 42 0.0007
482 CAESAREAN SECTION 8 0.0007
483 PULMONARY FUNCTION TEST DECREASED 3 0.0007
484 GINGIVAL SWELLING 3 0.0007
485 ISCHAEMIC STROKE 12 0.0007
486 PROTHROMBIN TIME PROLONGED 4 0.0007
487 BLOOD BILIRUBIN INCREASED 18 0.0007
488 BONE MARROW DISORDER 2 0.0007
489 PRESYNCOPE 16 0.0007
490 HAEMOGLOBIN INCREASED 3 0.0007
491 BLOOD UREA INCREASED 11 0.0007
492 DISEASE PROGRESSION 77 0.0007
493 PERICARDIAL EFFUSION 15 0.0006
494 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
495 HEPATIC STEATOSIS 12 0.0006
496 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
497 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
498 CARDIOGENIC SHOCK 9 0.0006
499 TUMOUR MARKER INCREASED 3 0.0006
500 SKIN INFECTION 7 0.0006
501 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
502 SENSORY LOSS 5 0.0006
503 STILLBIRTH 3 0.0006
504 SINUS BRADYCARDIA 6 0.0006
505 GASTROENTERITIS 9 0.0006
506 CHEST DISCOMFORT 63 0.0006
507 DEHYDRATION 82 0.0006
508 SEPSIS 68 0.0006
509 STAPHYLOCOCCAL SEPSIS 3 0.0006
510 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
511 ANEURYSM 3 0.0006
512 HYPERNATRAEMIA 3 0.0006
513 HEPATIC ENZYME ABNORMAL 3 0.0006
514 PAIN IN JAW 17 0.0006
515 HYPERAMMONAEMIA 3 0.0006
516 FULL BLOOD COUNT DECREASED 12 0.0006
517 CONJUNCTIVITIS 11 0.0006
518 RHINORRHOEA 38 0.0006
519 PETIT MAL EPILEPSY 3 0.0006
520 TOOTH DISORDER 13 0.0006
521 BREAST CANCER 54 0.0006
522 HYPERBILIRUBINAEMIA 6 0.0006
523 PERIORBITAL OEDEMA 3 0.0006
524 PYELONEPHRITIS 5 0.0006
525 PULMONARY HYPERTENSION 12 0.0006
526 PETECHIAE 6 0.0006
527 RIGHT VENTRICULAR FAILURE 4 0.0006
528 POLYARTHRITIS 3 0.0006
529 TUMOUR LYSIS SYNDROME 5 0.0006
530 PULMONARY EMBOLISM 54 0.0006
531 SUDDEN DEATH 6 0.0006
532 HYPERCALCAEMIA 7 0.0006
533 GENERALISED OEDEMA 7 0.0006
534 BEHAVIOUR DISORDER 3 0.0006
535 PALLOR 15 0.0006
536 ORAL DISORDER 4 0.0005
537 ERYTHEMA MULTIFORME 5 0.0005
538 FACE OEDEMA 9 0.0005
539 BLOOD CALCIUM DECREASED 6 0.0005
540 FLANK PAIN 5 0.0005
541 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
542 SQUAMOUS CELL CARCINOMA 5 0.0005
543 ABORTION INDUCED 5 0.0005
544 MYOCARDIAL ISCHAEMIA 6 0.0005
545 HEPATOCELLULAR CARCINOMA 4 0.0005
546 HAEMATURIA 18 0.0005
547 INFECTION 76 0.0005
548 EYE HAEMORRHAGE 7 0.0005
549 ACIDOSIS 4 0.0005
550 PULMONARY FIBROSIS 10 0.0005
551 BLOOD URIC ACID INCREASED 3 0.0005
552 HYPERVENTILATION 3 0.0005
553 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
554 RALES 3 0.0005
555 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
556 HAEMATEMESIS 13 0.0005
557 GASTROINTESTINAL INFLAMMATION 4 0.0005
558 HYPOMAGNESAEMIA 7 0.0005
559 BLEPHARITIS 2 0.0005
560 THYROID CANCER 6 0.0005
561 OSTEOMYELITIS 9 0.0005
562 DRUG INTOLERANCE 48 0.0005
563 EMPHYSEMA 5 0.0005
564 TASTE DISORDER 10 0.0005
565 TOOTH ABSCESS 5 0.0005
566 PALPITATIONS 57 0.0005
567 BREAST CANCER FEMALE 13 0.0005
568 PIGMENTATION DISORDER 3 0.0005
569 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
570 OLIGURIA 3 0.0005
571 AORTIC DISSECTION 2 0.0005
572 ACUTE CORONARY SYNDROME 4 0.0005
573 BACTERIAL INFECTION 9 0.0005
574 BLOOD SODIUM DECREASED 9 0.0005
575 FOLLICULITIS 5 0.0005
576 HYPOAESTHESIA 71 0.0005
577 GASTRIC CANCER 12 0.0005
578 PARAESTHESIA 74 0.0005
579 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
580 HEPATIC ENZYME INCREASED 32 0.0005
581 OCCUPATIONAL EXPOSURE TO PRODUCT 3 0.0005
582 BLOOD POTASSIUM DECREASED 14 0.0005
583 SKIN HYPERPIGMENTATION 4 0.0005
584 ANURIA 4 0.0005
585 SKIN ULCER 12 0.0005
586 PLATELET COUNT INCREASED 6 0.0005
587 OESOPHAGITIS 5 0.0005
588 HYPOGAMMAGLOBULINAEMIA 3 0.0005
589 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
590 MENTAL IMPAIRMENT 11 0.0005
591 NEURALGIA 11 0.0005
592 CATHETERISATION CARDIAC 2 0.0005
593 FACIAL PAIN 4 0.0004
594 BRONCHIECTASIS 3 0.0004
595 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
596 PNEUMOTHORAX 7 0.0004
597 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
598 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
599 CHRONIC MYELOID LEUKAEMIA 2 0.0004
600 APPENDICITIS 4 0.0004
601 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
602 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
603 ACUTE RESPIRATORY FAILURE 8 0.0004
604 AFFECT LABILITY 4 0.0004
605 PANIC REACTION 3 0.0004
606 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
607 CIRCULATORY COLLAPSE 7 0.0004
608 INJECTION SITE EXTRAVASATION 5 0.0004
609 ABDOMINAL TENDERNESS 2 0.0004
610 IMMUNODEFICIENCY 6 0.0004
611 HYDRONEPHROSIS 3 0.0004
612 HYPOTONIA 4 0.0004
613 DEEP VEIN THROMBOSIS 26 0.0004
614 DERMATITIS ALLERGIC 5 0.0004
615 TOXIC SKIN ERUPTION 4 0.0004
616 MUSCLE ATROPHY 5 0.0004
617 HAEMODYNAMIC INSTABILITY 3 0.0004
618 TINNITUS 18 0.0004
619 ABDOMINAL PAIN 91 0.0004
620 HEPATITIS 10 0.0004
621 ANXIETY 111 0.0004
622 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
623 THYROID DISORDER 6 0.0004
624 INFUSION SITE PAIN 5 0.0004
625 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
626 PERITONITIS 8 0.0004
627 HOT FLUSH 29 0.0004
628 THERAPY PARTIAL RESPONDER 6 0.0004
629 RESPIRATORY FAILURE 28 0.0004
630 BRAIN FOG 6 0.0004
631 INCONTINENCE 4 0.0004
632 LOW BIRTH WEIGHT BABY 3 0.0004
633 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
634 BREAST PAIN 4 0.0004
635 ASCITES 11 0.0004
636 JOINT RANGE OF MOTION DECREASED 5 0.0004
637 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
638 GASTRIC ULCER 7 0.0004
639 WOUND INFECTION 4 0.0004
640 CHOKING SENSATION 2 0.0004
641 THROMBOSIS 29 0.0004
642 COAGULOPATHY 6 0.0004
643 NERVE INJURY 4 0.0004
644 HYPERTENSIVE CRISIS 4 0.0004
645 BONE PAIN 21 0.0004
646 ORAL PAIN 8 0.0004
647 HAEMODIALYSIS 3 0.0004
648 INTESTINAL PERFORATION 4 0.0004
649 FACIAL PARALYSIS 3 0.0004
650 MICTURITION URGENCY 4 0.0003
651 CONSTIPATION 76 0.0003
652 BLOOD MAGNESIUM DECREASED 3 0.0003
653 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
654 COGNITIVE DISORDER 16 0.0003
655 DIARRHOEA 221 0.0003
656 AMENORRHOEA 6 0.0003
657 LUNG INFILTRATION 3 0.0003
658 PURPURA 3 0.0003
659 LOSS OF LIBIDO 3 0.0003
660 HEAVY MENSTRUAL BLEEDING 3 0.0003
661 RENAL IMPAIRMENT 28 0.0003
662 BACK PAIN 76 0.0003
663 PNEUMONIA BACTERIAL 3 0.0003
664 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
665 GRAND MAL CONVULSION 3 0.0003
666 CHILLS 38 0.0003
667 CHOLANGITIS 2 0.0003
668 DIARRHOEA HAEMORRHAGIC 3 0.0003
669 DYSPNOEA EXERTIONAL 12 0.0003
670 MYALGIA 54 0.0003
671 COLITIS 12 0.0003
672 PROTEINURIA 6 0.0003
673 RASH MACULO-PAPULAR 7 0.0003
674 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
675 PRODUCTIVE COUGH 15 0.0003
676 OEDEMA 17 0.0003
677 POLLAKIURIA 13 0.0003
678 LYMPHADENOPATHY 11 0.0003
679 ANOREXIA 4 0.0003
680 ANAPHYLACTIC SHOCK 8 0.0003
681 HYPOGLYCAEMIA 15 0.0003
682 RESPIRATORY TRACT INFECTION 8 0.0003
683 RENAL FAILURE ACUTE 13 0.0003
684 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
685 ASPERGILLUS INFECTION 2 0.0003
686 SHOCK 7 0.0003
687 GASTRITIS 8 0.0003
688 SYNCOPE 30 0.0003
689 SKIN DISORDER 10 0.0003
690 CELLULITIS 15 0.0003
691 SKIN EXFOLIATION 25 0.0003
692 DYSGEUSIA 22 0.0003
693 DRY THROAT 3 0.0003
694 LIMB INJURY 8 0.0003
695 EPILEPSY 9 0.0003
696 TACHYPNOEA 4 0.0003
697 LIVER DISORDER 13 0.0003
698 PERIPHERAL COLDNESS 4 0.0003
699 RESPIRATORY DISTRESS 8 0.0003
700 DIABETES MELLITUS 22 0.0003
701 DELIRIUM 10 0.0003
702 ABDOMINAL DISTENSION 30 0.0003
703 CHEST PAIN 53 0.0003
704 NEOPLASM MALIGNANT 19 0.0003
705 SKIN REACTION 4 0.0003
706 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
707 EATING DISORDER 6 0.0003
708 RETCHING 6 0.0003
709 AGEUSIA 7 0.0003
710 PARALYSIS 4 0.0003
711 HERPES ZOSTER 16 0.0003
712 BIPOLAR DISORDER 3 0.0003
713 PNEUMONIA 89 0.0003
714 INFUSION RELATED REACTION 18 0.0003
715 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
716 BLOOD PRESSURE DECREASED 18 0.0003
717 CATARACT 16 0.0003
718 OFF LABEL USE 235 0.0003
719 MALNUTRITION 3 0.0003
720 PAIN 164 0.0003
721 REBOUND EFFECT 3 0.0003
722 HYPOAESTHESIA ORAL 4 0.0003
723 LUNG DISORDER 13 0.0003
724 CARDIO-RESPIRATORY ARREST 11 0.0003
725 CHOLESTASIS 5 0.0003
726 BLOOD CREATININE INCREASED 17 0.0003
727 PHARYNGEAL OEDEMA 4 0.0003
728 SEIZURE 30 0.0003
729 TACHYCARDIA 23 0.0003
730 LUNG INFECTION 4 0.0003
731 HAEMORRHOIDS 5 0.0003
732 CHOLECYSTITIS 3 0.0003
733 PREMATURE DELIVERY 4 0.0003
734 HYPERLIPIDAEMIA 3 0.0003
735 RASH ERYTHEMATOUS 12 0.0003
736 ABSCESS 4 0.0003
737 BLOOD DISORDER 2 0.0002
738 CYTOKINE RELEASE SYNDROME 5 0.0002
739 NO THERAPEUTIC RESPONSE 3 0.0002
740 ABNORMAL FAECES 2 0.0002
741 IMPAIRED HEALING 8 0.0002
742 PHARYNGITIS 3 0.0002
743 FATIGUE 188 0.0002
744 DISTURBANCE IN ATTENTION 13 0.0002
745 LIVER FUNCTION TEST ABNORMAL 7 0.0002
746 BREAST CANCER STAGE II 2 0.0002
747 PERIPHERAL SWELLING 37 0.0002
748 RHABDOMYOLYSIS 10 0.0002
749 SKIN DISCOLOURATION 11 0.0002
750 ERYTHEMA 49 0.0002
751 PERICARDITIS 4 0.0002
752 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
753 OROPHARYNGEAL PAIN 22 0.0002
754 MUSCULAR WEAKNESS 27 0.0002
755 ATRIAL FIBRILLATION 23 0.0002
756 DYSPNOEA 132 0.0002
757 UNRESPONSIVE TO STIMULI 6 0.0002
758 APHASIA 7 0.0002
759 VAGINAL HAEMORRHAGE 10 0.0002
760 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
761 BLOOD CALCIUM INCREASED 2 0.0002
762 IMMUNE SYSTEM DISORDER 3 0.0002
763 DISORIENTATION 9 0.0002
764 HEPATOTOXICITY 5 0.0002
765 NERVOUS SYSTEM DISORDER 7 0.0002
766 PANCREATITIS ACUTE 5 0.0002
767 UVEITIS 3 0.0002
768 COUGH 62 0.0002
769 HYPERSENSITIVITY 41 0.0002
770 CONDITION AGGRAVATED 67 0.0002
771 ACUTE HEPATIC FAILURE 3 0.0002
772 METABOLIC ACIDOSIS 7 0.0002
773 DYSURIA 8 0.0002
774 DIVERTICULITIS 6 0.0002
775 FEELING COLD 6 0.0002
776 OXYGEN SATURATION DECREASED 12 0.0002
777 BLOOD TEST ABNORMAL 3 0.0002
778 OSTEONECROSIS 7 0.0002
779 HEPATIC CIRRHOSIS 4 0.0002
780 FUNGAL INFECTION 7 0.0002
781 EXPOSURE DURING PREGNANCY 13 0.0002
782 ABDOMINAL DISCOMFORT 35 0.0002
783 DIZZINESS 104 0.0002
784 BLOOD PRESSURE FLUCTUATION 5 0.0002
785 PANCREATITIS 11 0.0002
786 DEPRESSED MOOD 11 0.0002
787 ERUCTATION 4 0.0002
788 ADVERSE EVENT 19 0.0002
789 EAR PAIN 4 0.0002
790 ORAL HERPES 4 0.0002
791 ACUTE MYOCARDIAL INFARCTION 6 0.0002
792 RENAL FAILURE 27 0.0002
793 BLADDER DISORDER 2 0.0002
794 HYPERKALAEMIA 7 0.0002
795 ABDOMINAL PAIN LOWER 5 0.0002
796 OSTEOPENIA 3 0.0002
797 DRY MOUTH 16 0.0002
798 CEREBRAL HAEMORRHAGE 7 0.0002
799 DEVICE RELATED INFECTION 3 0.0002
800 LYMPHOMA 3 0.0002
801 MUSCULOSKELETAL PAIN 10 0.0002
802 OEDEMA PERIPHERAL 23 0.0002
803 IMPAIRED WORK ABILITY 4 0.0002
804 FLUSHING 19 0.0002
805 LIVER FUNCTION TEST INCREASED 4 0.0002
806 JAUNDICE 5 0.0002
807 POOR QUALITY SLEEP 4 0.0002
808 THROAT TIGHTNESS 5 0.0002
809 HYPOTENSION 37 0.0002
810 SWELLING FACE 12 0.0002
811 CHOLELITHIASIS 6 0.0002
812 VENTRICULAR TACHYCARDIA 3 0.0002
813 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
814 URINARY RETENTION 6 0.0002
815 FEELING HOT 11 0.0002
816 RASH 78 0.0002
817 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
818 ASTHMA 20 0.0002
819 PRODUCT AVAILABILITY ISSUE 4 0.0002
820 CONVULSION 10 0.0002
821 EPISTAXIS 13 0.0002
822 MULTI-ORGAN FAILURE 3 0.0002
823 MUSCLE TWITCHING 4 0.0002
824 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
825 HYPOXIA 6 0.0002
826 ABDOMINAL PAIN UPPER 35 0.0002
827 URINARY INCONTINENCE 5 0.0002
828 ATAXIA 2 0.0002
829 TOOTHACHE 3 0.0002
830 WEIGHT DECREASED 46 0.0002
831 BONE DISORDER 3 0.0002
832 HAEMATOCHEZIA 9 0.0002
833 ANAPHYLACTIC REACTION 9 0.0002
834 HEADACHE 102 0.0002
835 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
836 VISUAL IMPAIRMENT 20 0.0002
837 DRY EYE 8 0.0002
838 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
839 CARDIAC ARREST 13 0.0002
840 ACUTE KIDNEY INJURY 24 0.0002
841 DRUG RESISTANCE 4 0.0002
842 NIGHT SWEATS 5 0.0002
843 TOXICITY TO VARIOUS AGENTS 26 0.0002
844 DYSPHONIA 9 0.0002
845 MENORRHAGIA 3 0.0002
846 MALAISE 67 0.0002
847 PAIN IN EXTREMITY 45 0.0002
848 URINARY TRACT INFECTION 26 0.0002
849 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
850 VISUAL ACUITY REDUCED 5 0.0002
851 CARDIAC DISORDER 14 0.0001
852 LOSS OF CONSCIOUSNESS 19 0.0001
853 VERTIGO 9 0.0001
854 BODY TEMPERATURE INCREASED 3 0.0001
855 CORONARY ARTERY OCCLUSION 2 0.0001
856 MEMORY IMPAIRMENT 20 0.0001
857 HAEMOPTYSIS 4 0.0001
858 COORDINATION ABNORMAL 2 0.0001
859 BLISTER 8 0.0001
860 EYE PAIN 8 0.0001
861 SLEEP DISORDER 10 0.0001
862 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
863 ANOSMIA 2 0.0001
864 DYSSTASIA 4 0.0001
865 INFLAMMATION 7 0.0001
866 ARTHRALGIA 56 0.0001
867 COLON CANCER 2 0.0001
868 RESPIRATORY DISORDER 4 0.0001
869 CHROMATURIA 3 0.0001
870 DYSARTHRIA 5 0.0001
871 DYSPEPSIA 13 0.0001
872 BLOOD COUNT ABNORMAL 2 0.0001
873 INJECTION SITE ERYTHEMA 16 0.0001
874 BURNING SENSATION 9 0.0001
875 CYANOSIS 2 0.0001
876 ARRHYTHMIA 6 0.0001
877 NECK PAIN 7 0.0001
878 HEPATIC CANCER 3 0.0001
879 ENCEPHALOPATHY 3 0.0001
880 BRONCHITIS 9 0.0001
881 STAPHYLOCOCCAL INFECTION 4 0.0001
882 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
883 TYPE 2 DIABETES MELLITUS 4 0.0001
884 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
885 SWELLING 11 0.0001
886 HYPERHIDROSIS 15 0.0001
887 RASH GENERALISED 3 0.0001
888 ILL-DEFINED DISORDER 7 0.0001
889 MENTAL DISORDER 5 0.0001
890 MYOCARDIAL INFARCTION 20 0.0001
891 JOINT STIFFNESS 3 0.0001
892 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
893 PAIN OF SKIN 3 0.0001
894 THERAPY NON-RESPONDER 5 0.0001
895 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
896 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
897 SKIN LESION 3 0.0001
898 INFLUENZA LIKE ILLNESS 9 0.0001
899 MUSCLE SPASMS 20 0.0001
900 AGITATION 8 0.0001
901 RESPIRATORY ARREST 3 0.0001
902 HYPERTENSION 23 0.0001
903 PROCEDURAL PAIN 3 0.0001
904 MUSCULOSKELETAL STIFFNESS 9 0.0001
905 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
906 LACRIMATION INCREASED 3 0.0001
907 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
908 EMOTIONAL DISORDER 3 0.0001
909 LIMB DISCOMFORT 3 0.0001
910 DEATH 83 0.0001
911 DERMATITIS 2 0.0001
912 DRUG INTERACTION 15 0.0001
913 BRADYCARDIA 5 0.0001
914 CYSTITIS 3 0.0001
915 INSOMNIA 25 0.0001
916 DEPRESSION 21 0.0001
917 BLOOD PRESSURE INCREASED 14 0.0001
918 PRODUCT USE ISSUE 17 0.0001
919 MEDICATION ERROR 5 0.0001
920 PULMONARY OEDEMA 4 0.0001
921 THROAT IRRITATION 4 0.0001
922 INJECTION SITE PAIN 27 0.0001
923 SINUSITIS 9 0.0001
924 LETHARGY 5 0.0001
925 CONFUSIONAL STATE 14 0.0001
926 RENAL DISORDER 4 0.0001
927 COVID-19 15 0.0001
928 NASAL CONGESTION 5 0.0001
929 BLOOD GLUCOSE INCREASED 16 0.0001
930 COMA 4 0.0001
931 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
932 IRRITABILITY 5 0.0001
933 PANIC ATTACK 3 0.0001
934 INJECTION SITE MASS 3 0.0001
935 VISION BLURRED 11 0.0001
936 HALLUCINATION 6 0.0001
937 INTESTINAL OBSTRUCTION 3 0.0001
938 CARDIOVASCULAR DISORDER 2 0.0001
939 FLUID RETENTION 4 0.0001
940 TREMOR 13 0.0001
941 URTICARIA 13 0.0001
942 HAEMORRHAGE 8 0.0001
943 ECZEMA 4 0.0001
944 SPEECH DISORDER 4 0.0001
945 DRY SKIN 10 0.0001
946 ABORTION SPONTANEOUS 3 0.0001
947 TREATMENT NONCOMPLIANCE 4 0.0001
948 PRURITUS 28 0.0001
949 HEART RATE INCREASED 7 0.0001
950 RECTAL HAEMORRHAGE 3 0.0001
951 ANGINA PECTORIS 2 0.0001
952 MOBILITY DECREASED 5 0.0001
953 ANGIOEDEMA 3 0.0001
954 COLITIS ULCERATIVE 3 0.0001
955 CORONARY ARTERY DISEASE 2 0.0001
956 SKIN IRRITATION 3 0.0001
957 INJECTION SITE SWELLING 5 0.0001
958 NASOPHARYNGITIS 12 0.0001
959 CEREBROVASCULAR ACCIDENT 11 0.0001
960 DISEASE RECURRENCE 3 0.0001
961 MIGRAINE 6 0.0001
962 ANGER 2 0.0001
963 WEIGHT INCREASED 13 0.0001
964 SKIN BURNING SENSATION 4 0.0001
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
966 RASH PRURITIC 3 0.0001
967 NO ADVERSE EVENT 10 0.0001
968 CRYING 2 0.0001
969 ARTHROPATHY 3 0.0001
970 EYE IRRITATION 3 0.0001
971 SURGERY 3 0.0001
972 THERAPEUTIC RESPONSE DECREASED 3 0.0000
973 BLINDNESS 2 0.0000
974 ILLNESS 5 0.0000
975 DRUG INEFFECTIVE 62 0.0000
976 GAIT DISTURBANCE 9 0.0000
977 BALANCE DISORDER 4 0.0000
978 BLOOD CHOLESTEROL INCREASED 2 0.0000
979 JOINT SWELLING 5 0.0000
980 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
981 DERMATITIS ATOPIC 2 0.0000
982 FEELING ABNORMAL 9 0.0000
983 OVERDOSE 8 0.0000
984 INFLUENZA 4 0.0000
985 SOMNOLENCE 7 0.0000
986 SUICIDAL IDEATION 3 0.0000
987 FALL 10 0.0000
988 CHRONIC KIDNEY DISEASE 2 0.0000
989 ARTHRITIS 2 0.0000
990 COMPLETED SUICIDE 2 0.0000
991 PSORIASIS 3 0.0000
992 INCORRECT DOSE ADMINISTERED 4 0.0000